Metropolis Healthcare to invest Rs.500 mln to expand labs in 12th year

Metropolis Healthcare Ltd, a global chain of pathology labs and diagnostic centres, recently celebrated 12 successful years in Sri Lanka.

To mark this accomplishment, the company announced that it will invest Rs. 500 million to expand its laboratories and collection centres. This is in addition to the existing central laboratory in Nawala and six satellite laboratories along with strong network of collection centres already in operations.

During the last 12 years of opera- tions in Sri Lanka, Metropolis said in a media release that it has offered services to more than six million patients and conducted over 20 million tests, while more than 1000 Consultants have shown strong support and trust in Metropolis reports across the island.

Metropolis currently offers more than 4500 tests, a number which continues to grow with an addition of 50- 100 new tests every three years.

Avadhut Joshi, Senior Vice President, International Business, Metropolis Healthcare said “Over the last decade, we have earned the trust of doctors and patients through the quality of our reports and superior service. We have brought in automation, standard operating protocols, new tests and technologies and a fast turnaround time. We will continue to transform and advance laboratory testing in Sri Lanka.”

Metropolis Healthcare Ltd is present across India, South Asia, West Asia and Africa. Metropolis is led by Ameera Shah who serves as the Promoter and Managing Director of the group.